<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01824641</url>
  </required_header>
  <id_info>
    <org_study_id>T113E4</org_study_id>
    <nct_id>NCT01824641</nct_id>
  </id_info>
  <brief_title>Physiologic Assessment of Thrombus Aspiration in Acute ST-segment Elevation Myocardial Infarction Patients</brief_title>
  <acronym>PATA-STEMI</acronym>
  <official_title>The Randomized Physiologic Assessment of Thrombus Aspiration in Patients With Acute ST-segment Elevation Myocardial Infarction Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Centre of Serbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Center of nuclear medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institute for histology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinical Centre of Serbia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Physiologic Assessment of Thrombus Aspiration in ST-segment Elevation Myocardial&#xD;
      Infarction (PATA-STEMI) trial is a single center, prospective, randomized trial with a&#xD;
      planned inclusion of 128 patients with the first ST-segment elevation myocardial infarction&#xD;
      (STEMI). Patients are, before coronary angiography, randomly assigned to thrombus aspiration&#xD;
      using 6 or 7 French Eliminate aspiration catheter (Terumo Medical Supply, Japan) or to&#xD;
      conventional primary percutaneous coronary intervention (PCI). The primary endpoint is index&#xD;
      of microcirculatory resistance (IMR), measured in infarct-related artery, in thrombus&#xD;
      aspiration compared to conventional PCI group.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background and Objective Routine thrombus aspiration is superior to conventional primary PCI&#xD;
      in terms of improved myocardial perfusion in STEMI patients. However, myocardial perfusion&#xD;
      after thrombus aspiration has not been evaluated by a quantitative, invasive method.&#xD;
      Investigators intend to determine whether thrombus aspiration of the infarct-related artery&#xD;
      increases myocardial perfusion, as measured by IMR, compared to conventional primary PCI.&#xD;
&#xD;
      Study design PATA-STEMI is a single center, prospective, randomized trial with a planned&#xD;
      inclusion of 128 patients with the first STEMI. Patients are randomly assigned, before&#xD;
      coronary angiography, to thrombus aspiration using the 6 or 7 French Eliminate aspiration&#xD;
      catheter (Terumo Medical Supply, Japan) or to conventional primary PCI. The IMR will be&#xD;
      determined in infarct-related artery and non-infarct-related arteries without critical&#xD;
      stenosis to measure microcirculatory resistance. The primary endpoint is defined as IMR in&#xD;
      infarct-related artery in thrombus aspiration compared to conventional PCI group. Secondary&#xD;
      end points are myocardial perfusion grade and resolution of ST-segment elevation, infarct&#xD;
      size and left ventricle remodeling, as assessed by echocardiographic indices. Transthoracic&#xD;
      echocardiography will be conducted within 24 hours and at 4 months after the primary PCI.&#xD;
&#xD;
      Implications: If manual thrombus aspiration reduces microcirculatory resistance, indicating&#xD;
      improved myocardial perfusion, as compared to conventional PCI, it might become the preferred&#xD;
      strategy in patients with STEMI.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">November 2013</completion_date>
  <primary_completion_date type="Anticipated">May 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IMR (mmHg seconds) in thrombus aspiration compared to conventional PCI group</measure>
    <time_frame>At the end of the primary PCI , an expected average of 45 minutes after sheath insertion</time_frame>
    <description>IMR will be measured after final balloon inflation or stent implantation, an expected average of 45 minutes after sheath insertion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resolution of ST-segment elevation</measure>
    <time_frame>at 60 minutes after guiding catheter removal</time_frame>
    <description>ST-segment resolution ≥70% at 60 minutes after guiding catheter removal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>myocardial blush grade (0-3)</measure>
    <time_frame>at final angiogram, an expected average of 55 minutes after sheath insertion</time_frame>
    <description>myocardial blush grade will be assessed after IMR measurements, following the final balloon inflation or stent implantation, an expected average of 55 minutes after sheath insertion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>infarct size assessed by peak enzyme release (Troponin, creatine kinase MB (CK-MB))</measure>
    <time_frame>in hospital course after primary PCI, an expected average of 5 days</time_frame>
    <description>infarct size will be determined based on peak enzyme release (Troponin, CK-MB) during in-hospital stay, an expected average of 5 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>indices of left ventricle remodeling on Echocardiography</measure>
    <time_frame>within 24 hours and at 4 months after primary PCI</time_frame>
    <description>left ventricle remodeling will be assessed on Echocardiography within 24 hours and at 4 months after primary PCI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>infarct size determined by SPECT</measure>
    <time_frame>within 7-14 days and at 4 months after primary PCI</time_frame>
    <description>infarct size will be determined by SPECT within 7-14 days and at 4 months after primary PCI</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Eliminate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eliminate aspiration catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional primary angioplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients treated with conventional primary angioplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Eliminate aspiration catheter</intervention_name>
    <description>Eliminate aspiration catheter</description>
    <arm_group_label>Eliminate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional primary angioplasty</intervention_name>
    <description>Primary angioplasty without thrombus aspiration</description>
    <arm_group_label>Conventional primary angioplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All consecutive patients with STEMI&#xD;
&#xD;
          -  chest pain onset ≤12h, or &gt;12 h with persistent ST-segment elevation&#xD;
&#xD;
          -  hemodynamically stable patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients without diagnosis of STEMI (pericarditis, for example)&#xD;
&#xD;
          -  no written informed consent obtained&#xD;
&#xD;
          -  prior Q or non-Q MI&#xD;
&#xD;
          -  prior resuscitation&#xD;
&#xD;
          -  prior thrombolysis&#xD;
&#xD;
          -  prior surgical myocardial revascularisation&#xD;
&#xD;
          -  life expectancy &lt;6 months&#xD;
&#xD;
          -  periprocedural death&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dejan Orlic, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Center of Serbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dejan Milasinovic, MD</last_name>
    <phone>+381113613653</phone>
    <email>dejan_milasinovic@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Goran Stankovic, MD, PhD</last_name>
    <phone>+381113615433</phone>
    <email>gorastan@sbb.rs</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinical center of Serbia</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milorad Tesic, MD</last_name>
      <phone>+381113615433</phone>
      <email>misa.tesic@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Miodrag Ostojic, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Branko Beleslin, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Goran Stankovic, Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sinisa Stojkovic, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vladan Vukcevic, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milica Borovic, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dragana Sobic-Saranovic, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milorad Tesic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dejan Milasinovic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milan Dobric, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zlatko Mehmedbegovic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milan Nedeljkovic, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milorad Zivkovic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vladimir Dedovic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Center of Serbia</name>
      <address>
        <city>Belgrade</city>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dejan Orlic</last_name>
      <phone>+381113615433</phone>
    </contact>
    <investigator>
      <last_name>Dejan Orlic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Serbia</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <study_first_submitted>March 22, 2013</study_first_submitted>
  <study_first_submitted_qc>April 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 5, 2013</study_first_posted>
  <last_update_submitted>April 2, 2013</last_update_submitted>
  <last_update_submitted_qc>April 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Centre of Serbia</investigator_affiliation>
    <investigator_full_name>Dejan Orlic</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Acute myocardial infarction</keyword>
  <keyword>Manual thrombus aspiration</keyword>
  <keyword>Coronary physiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

